I said that MON may underperform other global companies. MON has headwinds now and the easy growth is maybe over?
I would respectfully disagree. How can the world’s growing population possibly be fed if MON (and the other companies in the ag-biotech business) do not continue to grow by developing better-yielding seeds? Cities are not going to be converted back to farmland, so the amount of worldwide arable land is probably close to its peak—if it has not peaked already.
When Greenpeace goes after a company they have a lot of clout…
Indeed they do, and this is one reason many European countries have not allowed biotech crops to be grown on their own soil—although they (hypocritically) do permit importation of grain grown using biotech seeds planted elsewhere.
Then we have the…health studies showing the negatives of GMO surfacing.
If you know of studies from a scientifically credible source without a political agenda that show harm to human health from consuming grain derived from biotech seeds, please let me know—I’m not aware of any.
Many people confuse cross pollination that has brought us nice things like seedless oranges and grapes, but GM food is basically new food.
In case you didn’t know: MON spends about 50% of its R&D on conventional (non-biotech) breeding. Regards, Dew
Seed companies including Monsanto Co. (MON), the world’s largest, will get speedier regulatory reviews of their genetically modified crops under forthcoming rule changes, the U.S. Department of Agriculture said.
The goal is to cut by half the time needed to approve biotech crops from the current average of three years, Michael Gregoire, a USDA deputy administrator, said today in a telephone interview. The changes will take effect when they’re published in the Federal Register, probably in March, he said.
Approvals that took six months in the 1990s have lengthened because of increased public interest, more legal challenges and the advent of national organic food standards, Gregoire said. U.S. farmers worry they may be disadvantaged as countries such as Brazil approve new technologies faster[e.g. #msg-55517002], said Steve Censky, chief executive officer of the American Soybean Association.
“It is a concern from a competition standpoint,” Censky said in a telephone interview.
One way the USDA plans to speed up approvals is by inviting public comments as soon as seed developers such as Monsanto and DuPont Co. (DD) file a complete petition for deregulation of a biotech crop, rather than waiting until the end of the review, Gregoire said. That will allow regulators at the USDA’s Animal and Plant Health Inspection Service, or APHIS, to address any concerns as they conduct their environmental analysis and risk assessment, he said.
Budget Increase
“We can improve the quality of decisions by providing for this earlier public input in the process,” Gregoire said. “We are not sacrificing quality at all.”
Congress is helping to speed crop reviews by increasing APHIS’s budget for biotech regulation to a record $18 million this year, from $13 million in 2011, Gregoire said.
The Center for Food Safety, a Washington-based non-profit group that has successfully challenged approvals of Monsanto’s Roundup Ready sugar-beet and alfalfa crops, said the rule change is aimed at preventing opponents of modified crops from voicing criticism of the agency’s methods.
“They are trying to work the system so they can dismiss public comments more quickly and easily in order to speed things up,” Bill Freese, a policy analyst at the group, said in a telephone interview. “It’s a rubber-stamp system. A real regulatory system will occasionally reject something.”
Under the rule changes, new versions of existing crop technologies, such as corn that produces a naturally occurring pesticide, would undergo a review lasting about 13 months, Gregoire said. That would be accomplished by making the agency’s determination final after a 30-day public review period, he said.
For new technologies, such as a crops engineered to tolerate a new herbicide, there will be a second comment period after the agency makes its preliminary decision, extending the overall duration of the review to about 16 months, he said.
Which of these two regulatory routes is taken for each of the 22 biotech crops currently under review will be announced along with the publication of the rule change, Gregoire said.‹